The Company has been extremely busy in the period since our last report. This CEO Activities Report provides context and further information on the highlights of last quarter. In summary:
- Important relationships were forged or further developed with industry partners. Key announcements were released covering the following:
- The launch of a new in-vivo research partnership with The University of Queensland,
- An endorsement of Anteo’s AMG Activation Kit by Luminex Systems; and
- Execution of a new agreement with global healthcare company, POC1, which followed an initial 18 month feasibility study in point of care testing.
Immediately after the reporting period, we also provided an update on the relationship with IMRA America, and the news that Anteo’s Mix&Go range will be incorporated into the Sigma Aldrich catalogue.